GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders.
作者信息
Leggio Lorenzo, Hendershot Christian S, Farokhnia Mehdi, Fink-Jensen Anders, Klausen Mette Kruse, Schacht Joseph P, Simmons W Kyle
机构信息
Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, MD, USA.
Bowles Center for Alcohol Studies and Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
出版信息
Nat Med. 2023 Dec;29(12):2993-2995. doi: 10.1038/s41591-023-02634-8.
PMID:38001271
Abstract
摘要
Zotero 插件